|
Sign In to gain access to subscriptions and/or personal tools.
|
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
LB Tucker
Division of Pediatric Rheumatology, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia, Canada
AG Uribe
Division of Pediatric Rheumatology, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia, Canada
M Fernández
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
LM Vilá
Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA
G McGwin
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
M Apte
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
BJ Fessler
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
HM Bastian
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
JD Reveille
Department of Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA
GS Alarcón
Division of Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
The objective of this study is to examine the clinical features and outcomes of patients with systemic lupus erythematosus (SLE) whose disease began in adolescence [juvenile-onset SLE (jSLE)] compared with adult-onset patients [adult-onset SLE (aSLE)] from a large multiethnic cohort. Systemic lupus erythematosus patients of African-American, Caucasian, or Hispanic ethnicity and 1 year follow-up were studied in two groups: jSLE (diagnosed at 18 years); aSLE (diagnosed at 19–50 years; matched for gender and disease duration at enrolment). Sociodemographic data, SLE manifestations, disease activity, damage accrual, SLE-related hospitalizations or emergency room visits, drug utilization, mortality and psychosocial characteristics and quality of life were compared. Data were analysed by univariable and multivariable analyses. Seventy-nine patients were studied (31 jSLE, 48 aSLE); 90% were women. Mean (SD) total disease duration was 6.8 (2.7) years in jSLE and 5.6 (3.3) years in aSLE (p = 0.077). Mean age at cohort entry was 18.4 (1.8) and 33.9 (9.2) years in jSLE and aSLE respectively. By univariable analysis, jSLE patients were more commonly of African-American descent, were more likely to have renal and neurological involvements, and to accrue renal damage; jSLE patients had lower levels of helplessness and scored higher in the physical component measure of the SF-36 than aSLE patients. Renal involvement [OR = 1.549, 95% CI (1.397–15.856)] and neurological involvement [OR = 1.642, 95% CI (1.689–15.786)] were independently associated with jSLE by multivariable analysis. There was a larger proportion of African-Americans within the jSLE group. After adjusting for ethnicity and follow-up time, jSLE patients experienced more renal and neurological manifestations, with more renal damage. There was a two-fold higher mortality rate in the jSLE group.
Key Words: juvenile-onset SLE outcome
Lupus, Vol. 17, No. 4,
314-322 (2008)
DOI: 10.1177/0961203307087875

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. T. HIRAKI, S. M. BENSELER, P. N. TYRRELL, E. HARVEY, D. HEBERT, and E. D. SILVERMAN
Ethnic Differences in Pediatric Systemic Lupus Erythematosus
J Rheumatol,
November 1, 2009;
36(11):
2539 - 2546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. I. BRUNNER, G. C. HIGGINS, K. WIERS, S. K. LAPIDUS, J. C. OLSON, K. ONEL, M. PUNARO, J. YING, M. S. KLEIN-GITELMAN, and M. SEID
Health-related Quality of Life and Its Relationship to Patient Disease Course in Childhood-onset Systemic Lupus Erythematosus
J Rheumatol,
July 1, 2009;
36(7):
1536 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Descloux, I. Durieu, P. Cochat, D. Vital-Durand, J. Ninet, N. Fabien, and R. Cimaz
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus
Rheumatology,
July 1, 2009;
48(7):
779 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I E A Hoffman, B R Lauwerys, F De Keyser, T W J Huizinga, D Isenberg, L Cebecauer, J Dehoorne, R Joos, G Hendrickx, F Houssiau, et al.
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
Ann Rheum Dis,
March 1, 2009;
68(3):
412 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S Alarcon
Lessons from LUMINA: a multiethnic US cohort
Lupus,
November 1, 2008;
17(11):
971 - 976.
[PDF]
|
 |
|
|
|